Blue Earth Diagnostics
Healthcare Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
The Oxford Science Park Magdalen Centre ...Phone Number
+44 1865784186Website
www.blueearthdiagnostics.comRevenue
$18 MillionIndustry
ZI Rank: 9
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
7
5
6
4
12
9
About Blue Earth Diagnostics
Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., is an established molecular imaging company on a growth trajectory to provide innovative, well differentiated diagnostics solutions, informing patients and driving future therapies in cancer. Formed in 2014, Blue Earth Diagnostics success is driven by its management expertise and agility, supported by a demonstrated track record of rapid development and commercialisation of positron emission tomography (PET) radiopharmaceuticals. Blue Earth Diagnostics clinical focus is exclusively in cancer, with an expanding pipeline in disease states. Blue Earth Diagnostics strategy is to apply its knowledge and expertise to developing promising cancer radiopharmaceuticals for imaging.Explore more
Blue Earth Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Blue Earth Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Blue Earth Diagnostics had a recent Job posting/layoffs
Earning: See what the market has to say on Blue Earth Diagnostics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Blue Earth Diagnostics
Funding: Get notified immidiatlly once Blue Earth Diagnostics has new funding data
Check if Blue Earth Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Check out if Blue Earth Diagnostics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Blue Earth Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Blue Earth Diagnostics launches new products
Recommended Actions
Reach out to Masked Content who joined Blue Earth Diagnostics as Masked Content
Find more new buyers
Compare Similar Companies to Blue Earth Diagnostics
Compare insights from companies similar to Blue Earth Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Blue Earth Diagnostics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Blue Earth Diagnostics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Blue Earth Diagnostics.
Blue Earth Diagnostics financials insights
Gather financial insights about Blue Earth Diagnostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$21.4M
2019
Series B
$9M
Blue Earth Diagnostics Tech Stack
A closer look at the technologies used by Blue Earth Diagnostics
See more technologies
Most Recent Scoops
Open Position
Open Position
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
, according to a mid-level source in advertising & promotion, is planning to leverage AI-driven lead generation and personalization over the next three months.
Advertising, Artificial Intelligence, Lead Generation
Pain Point
Pain Point, Advertising
Blue Earth Diagnostics News & Media
Bracco Imaging and NYU Langone Health Announce Strategic Alliance Agreement to Advance Medical Imaging Innovation
Multi-year research agreement aims to advance innovation in MRI, CT, Ultrasound and PET/CT imaging MILAN, April 20, 2026 /PRNewswire/ -- Bracco Imaging today announced a strategic alliance with NYU Langone Health to advance innovation in medical imaging through the signing of a multi-year...Blue Earth Diagnostics Announces Positive Results from Head-to-Head Comparator Study of POSLUMA® (Flotufolastat F 18) and Piflufolastat F 18 Urinary Bladder Radioactivity in Men with Biochemical Recurrence of Prostate Cancer
BOSTON, Feb. 27, 2026 /PRNewswire/ -- Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced results from the first head-to-head study comparing urinary...Blue Earth Diagnostics to Highlight New POSLUMA® (Flotufolastat F 18) Study Results in Prostate Cancer at the 2026 ASCO Genitourinary Symposium (ASCO GU)
BOSTON, Feb. 18, 2026 /PRNewswire/ -- Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced that multiple presentations featuring POSLUMA®...Blue Earth Diagnostics, a Bracco Company, Applauds New CMS Rule to Support Patient Access Through Improved Payment for Specialized Diagnostic Radiopharmaceuticals
MONROE TOWNSHIP, N.J., & OXFORD, England--(BUSINESS WIRE)--Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, welcomes changes announced by the Centers for Medicare & Medicaid Services (CMS) for the Hospital Outpatient Prospective Payment System (OPPS) Rule on November 1, 2024. The rule, which goes into effect January 1, 2025, is designed to improve payments for diagnostic radiopharmaceuticals for U
Read more news
Top Healthcare Services Companies
See more top companies
Frequently Asked Questions Regarding Blue Earth Diagnostics
Sign Up For FreeTo access detailed company insights
Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., is an established molecular imaging company on a growth trajectory to provide innovative, well differentiated diagnostics solutions, informing patients and driving future therapies in cancer. Formed in 2014, Blue Earth Diagnostics success is driven by its management expertise... Read More
